NPI Details
DR. Andrew Malcolm Mcalpin, MD is an internal medicine in Lander, WY. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Andrew Malcolm Mcalpin, MD NPI is 1386714129. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
745 BUENA VISTA DR
LANDER, WY
ZIP 82520-431
Phone: (307) 332-2941
Fax: (307) 332-1920
The NPI 1386714129 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Hemoglobin a1c level (HCPCS:83036)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Blood test, clotting time (HCPCS:85610)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Annual depression screening, 15 minutes (HCPCS:G0444)
- Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
- Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Electrocardiogram (ecg) 2-day continuous with review and report by health care professional (HCPCS:93224)
- Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
- Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
- Advance care planning, first 30 minutes (HCPCS:99497)
- Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
- X-ray of chest, 2 views (HCPCS:71046)
- Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
- Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
- Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
- Pneumococcal vaccine, 23-valent (HCPCS:90732)
- Ferritin (blood protein) level (HCPCS:82728)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
- Iron level (HCPCS:83540)
- Iron binding capacity (HCPCS:83550)
- Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
- Transitional care management services for problem of high complexity (HCPCS:99496)
- Screening 3d breast mammography (HCPCS:77063)
- Screening mammography (HCPCS:77067)
The enumeration date for this NPI number is 11/9/2006 and was last updated on 5/25/2022.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 221996-1 | NEW YORK | No |
| 2 | 207R00000X | Internal Medicine | | DR-45096 | COLORADO | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 811431 | MEDICAID | ARIZONA | |
| 2 | 94021881 | MEDICAID | NEW MEXICO | |
